Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,566 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Austrian clinical practice with anidulafungin in 2008: a multicenter survey.
Perkhofer S, Hell M, Gustorff B, Von Goedecke A, Illievich U, Kratzer C, Moosbauer W, Wimmer P, Zerlauth U, Nachbaur K, Vogel W, Bellmann R, Schwameis F, Lass-Flörl C. Perkhofer S, et al. Among authors: vogel w. J Chemother. 2011 Oct;23(5):285-9. doi: 10.1179/joc.2011.23.5.285. J Chemother. 2011. PMID: 22005061
Impact of single-room contact precautions on acquisition and transmission of vancomycin-resistant enterococci on haematological and oncological wards, multicentre cohort-study, Germany, January-December 2016.
Biehl LM, Higgins PG, Stemler J, Gilles M, Peter S, Dörfel D, Vogel W, Kern WV, Gölz H, Bertz H, Rohde H, Klupp EM, Schafhausen P, Salmanton-García J, Stecher M, Wille J, Liss B, Xanthopoulou K, Zweigner J, Seifert H, Vehreschild MJGT. Biehl LM, et al. Among authors: vogel w. Euro Surveill. 2022 Jan;27(2):2001876. doi: 10.2807/1560-7917.ES.2022.27.2.2001876. Euro Surveill. 2022. PMID: 35027104 Free PMC article.
[18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma.
Vos JL, Zuur CL, Smit LA, de Boer JP, Al-Mamgani A, van den Brekel MWM, Haanen JBAG, Vogel WV. Vos JL, et al. Among authors: vogel wv. Eur J Nucl Med Mol Imaging. 2022 May;49(6):2010-2022. doi: 10.1007/s00259-021-05610-x. Epub 2021 Dec 27. Eur J Nucl Med Mol Imaging. 2022. PMID: 34957526 Free PMC article. Clinical Trial.
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.
Vos JL, Elbers JBW, Krijgsman O, Traets JJH, Qiao X, van der Leun AM, Lubeck Y, Seignette IM, Smit LA, Willems SM, van den Brekel MWM, Dirven R, Baris Karakullukcu M, Karssemakers L, Klop WMC, Lohuis PJFM, Schreuder WH, Smeele LE, van der Velden LA, Bing Tan I, Onderwater S, Jasperse B, Vogel WV, Al-Mamgani A, Keijser A, van der Noort V, Broeks A, Hooijberg E, Peeper DS, Schumacher TN, Blank CU, de Boer JP, Haanen JBAG, Zuur CL. Vos JL, et al. Among authors: vogel wv. Nat Commun. 2021 Dec 22;12(1):7348. doi: 10.1038/s41467-021-26472-9. Nat Commun. 2021. PMID: 34937871 Free PMC article. Clinical Trial.
Time-dependent analysis of adoptive immunotherapy following sequential FLAMSA-reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk myeloid neoplasia.
Weller JF, Mezger M, Seifert LL, Vogel W, Schneidawind D, Faul C, Bethge W, Lengerke C, Christopeit M. Weller JF, et al. Among authors: vogel w. Eur J Haematol. 2022 Mar;108(3):244-263. doi: 10.1111/ejh.13732. Epub 2021 Dec 23. Eur J Haematol. 2022. PMID: 34902880
Chromothripsis followed by circular recombination drives oncogene amplification in human cancer.
Rosswog C, Bartenhagen C, Welte A, Kahlert Y, Hemstedt N, Lorenz W, Cartolano M, Ackermann S, Perner S, Vogel W, Altmüller J, Nürnberg P, Hertwig F, Göhring G, Lilienweiss E, Stütz AM, Korbel JO, Thomas RK, Peifer M, Fischer M. Rosswog C, et al. Among authors: vogel w. Nat Genet. 2021 Dec;53(12):1673-1685. doi: 10.1038/s41588-021-00951-7. Epub 2021 Nov 15. Nat Genet. 2021. PMID: 34782764
1,566 results